Search results
Beacon raises $170M for eye gene therapy; J&J confirms Carvykti survival benefit
BioPharma Dive· 2 days agoForbion led the startup’s Series B round. Elsewhere, Vertex got an FDA decision date for its “vanza...
The state of oligonucleotide therapeutic manufacturing: what biopharmaceutical players need to know
Pharmaceutical Technology· 3 days agoIn the genomic medicine toolbox, oligonucleotide therapeutics offer highly specific and effective...